Current readings: management of N2 disease for lung cancer
- PMID: 24952759
- DOI: 10.1053/j.semtcvs.2014.02.008
Current readings: management of N2 disease for lung cancer
Abstract
The optimal management of locally advanced, Stage IIIA NSCLC with N2 level nodal metastases remains challenging and controversial. A number of treatment regimens have been shown safe and effective, but existing clinical trial data frequently falls short of providing guidance to match the right approach with the right patient. We review recent literature in this area and its impact.
Keywords: N2 NSCLC; chemotherapy; genomics; lung cancer; radiation therapy; surgery; targeted therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.
Comment on
-
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.Lancet. 2009 Aug 1;374(9687):379-86. doi: 10.1016/S0140-6736(09)60737-6. Epub 2009 Jul 24. Lancet. 2009. PMID: 19632716 Free PMC article. Clinical Trial.
-
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection.J Thorac Oncol. 2012 Feb;7(2):365-9. doi: 10.1097/JTO.0b013e31823a385f. J Thorac Oncol. 2012. PMID: 22237260 Free PMC article.
-
Management of stage IIIA non-small cell lung cancer by thoracic surgeons in North America.Ann Thorac Surg. 2012 Sep;94(3):922-6; discussion 926-8. doi: 10.1016/j.athoracsur.2012.04.087. Epub 2012 Jun 27. Ann Thorac Surg. 2012. PMID: 22742842
-
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.Ann Thorac Surg. 2012 Sep;94(3):914-20. doi: 10.1016/j.athoracsur.2012.04.088. Epub 2012 Jul 21. Ann Thorac Surg. 2012. PMID: 22819472 Free PMC article.
-
Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens.Ann Thorac Surg. 2013 May;95(5):1708-16. doi: 10.1016/j.athoracsur.2013.02.041. Epub 2013 Mar 29. Ann Thorac Surg. 2013. PMID: 23545194
-
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.J Clin Oncol. 2013 Jun 10;31(17):2167-72. doi: 10.1200/JCO.2012.47.7737. Epub 2013 Apr 29. J Clin Oncol. 2013. PMID: 23630207
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical